Catalysts for Takeda Pharmaceuticals USA Inc
143 tracked
Jul 30, 2014
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jul 24, 2014
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jul 24, 2014
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jul 18, 2014
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jul 18, 2014
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
May 20, 2014
approval
ENTYVIO (VEDOLIZUMAB) — FDA approval
Takeda Pharmaceuticals USA Inc
→
May 14, 2014
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Mar 27, 2014
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 30, 2014
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 20, 2013
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 20, 2013
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 6, 2013
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 3, 2013
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Aug 12, 2013
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jun 25, 2013
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jun 14, 2013
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jun 14, 2013
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Apr 26, 2013
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Mar 8, 2013
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 14, 2012
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 19, 2012
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 19, 2012
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 19, 2012
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Feb 7, 2012
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 31, 2012
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Sep 1, 2011
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Mar 16, 2011
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 12, 2010
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 12, 2010
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 10, 2010
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→